Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01EX51 L01EX51 Acalabrutinib
L01EX52 L01EX52 Quizartinib
L01EX53 L01EX53 Larotrectinib
L01EX54 L01EX54 Gilteritinib
L01EX56 L01EX56 Entrectinib
L01EX57 L01EX57 Fedratinib
L01F L01F Monoclonal antibodies and antibody drug conjugates
L01FA L01FA CD20 (Clusters of Differentiation 20) inhibitors
L01FA01 L01FA01 Rituximab
L01FA02 L01FA02 Ofatumumab
L01FA03 L01FA03 Obinutuzumab
L01FB L01FB CD22 (Clusters of Differentiation 22) inhibitors
L01FB01 L01FB01 Inotuzumab ozogamicin
L01FB02 L01FB02 Moxetumomab pasudotox
L01FC L01FC CD38 (Clusters of Differentiation 38) inhibitors
L01FC01 L01FC01 Daratumumab
L01FC02 L01FC02 Isatuximab
L01FD L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
L01FD01 L01FD01 Trastuzumab
L01FD02 L01FD02 Pertuzumab
L01FD03 L01FD03 Trastuzumab emtansine
L01FD04 L01FD04 Trastuzumab deruxtecan
L01FD05 L01FD05 Trastuzumab duocarmazine
L01FD06 L01FD06 Margetuximab
L01FD07 L01FD07 Zanidatamab
L01FE L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors
L01FE01 L01FE01 Cetuximab
L01FE02 L01FE02 Panitumumab
L01FE03 L01FE03 Necitumumab
L01FF L01FF PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
Showing 30 of 6884 Records